Skip to main content
. Author manuscript; available in PMC: 2010 Dec 22.
Published in final edited form as: Curr Eye Res. 2010 Dec;35(12):1142–1147. doi: 10.3109/02713683.2010.512114

FIGURE 1.

FIGURE 1

Representative eyes 48 hr PI. Eyes were treated with PBS (A), cholesterol (B), moxifloxacin (C), or moxifloxacin/cholesterol (D). Haziness and hypopyon (black arrow) were observed in eyes treated with PBS, cholesterol, or moxifloxacin. Infiltrate (white arrow) at the site of injection was observed in eyes from all treatment groups.